Erratic behavior of nitric oxide within the immune system: Illustrative review of conflicting data and their immunopharmacological aspects

International Journal of Immunopharmacology

Volumn 20, Issue 7, 1998, Pages 319-343

  Zidek, Z ^a   Masek K ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Immunity; Nitric oxide; Review

Indexed keywords

AMINOGUANIDINE; ARGINASE; ARGININE; CYCLIC AMP; CYTOKINE; DEFEROXAMINE; GROWTH FACTOR; IRON; LYMPHOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; PROSTAGLANDIN;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; ENDOTOXEMIA; ENTERITIS; HUMAN; IMMUNITY; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ANIMALS; APOPTOSIS; ARGININE; AUTOIMMUNE DISEASES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTOXEMIA; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE SYSTEM; INFECTION; INFLAMMATORY BOWEL DISEASES; ISOENZYMES; MICE; NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; RATS; SPECIES SPECIFICITY;

EID: 0344784430     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00036-8     Document Type: Review

References (293)

1. Adams, D.O., Kao, K.-J., Farb, R., & Pizzo, S.V. (1980). Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases. J. Immunol. 124, 286-292.
2. Adams, L.B., Hibbs, J.B., Jr., Taintor, R.R., & Krahenbuhl, J.L. (1990). Micro-biostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144, 2725-2729.
3. Akaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K., Suga, M., Zheng, Y.M., Dietzschold, B., & Maeda, H. (1996). Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. U.S.A. 93, 2448-2453.
4. Albina, J.E., Mills, C.D., Henry, W.L., Jr., & Caldwell, M.D. 1989. Regulation of macrophage physiology by L-arginine: Role of the oxidative L-arginine deiminase pathway. J. Immunol. 143, 3641-3646.
5. Albina, J.E., Cui, S., Mateo, R.B., & Reichner J.S. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150, 5080-5085.
6. Alford, C.E., King, T.E., Jr., & Campbell, P.A. (1991). Role of transferrin receptors and iron in macrophage listericidal activity. J. Exp. Med. 174, 459-466.
7. Ankarcrona, M., Dypbukt, J.M., Brüne, B., & Nicotera, P. (1994). Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp. Cell Res. 213, 172-177.
8. Anthony, L.S.D., Morrissey, P.J., & Nano, F.E. (1992). Growth inhibition of Francisella tularensis live vaccine strain by IFN-γ-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J. Immunol. 148, 1829-1834.
9. Appelberg, R., & Orme, L.M. (1993). Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology 80, 352-359.
10. Assreuy, J., Cunha, F.Q., Epperlein, M., Noronha-Dutra, A., O'Donnell, C.A., Liew, F.Y., & Moncada, S. (1994). Production of nitric oxide and super-oxide by activated macrophages and killing of Leishmania major. Eur. J. Immunol. 24, 672-676.
11. Avontuur, J.A.M., Bruining, H.A., & Ince, C. (1995). Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ. Res. 76, 418-425.
12. Baek, K.J., Thiel, B.A., Lucas, S., & Stuehr, D.J. (1993). Macrophage nitric oxide synthase subunits: purification, characterization and role of prosthetic groups and substrates in regulating their association into a dimeric enzyme. J. Biol. Chem. 268, 21120-21129.
13. Bagetta, G., Corasaniti, M.T., Melino, G., Paoletti, A.M., Finazzi-Agro, A., & Nistico, G. (1993). Lithium and tacrine increase the expression of nitric oxide synthase mRNA in the hippocampus of rat. Biochem. Biophys. Res. Commun. 197, 1132-1139.
14. Balligand, J.-L., Ungureanu, D., Kelly, R.A., Kobzik, L., Pimental, D., Michel, T., & Smith, T.W. (1993). Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91, 2314-2319.
15. + in activated macrophages. Biochem. Biophys. Res. Commun. 200, 726-731.
16. 2 and nitric oxide; in vitro studies. Immunol. Lett. 37, 27-33.
17. Benninhoff, B., Lehman, V., Eck. H.P., & Droge, W. (1991). Production of citrulline and ornithine by interferon-gamma treated macrophages. Int. Immunol. 3, 413-417.
18. Bermudez, L.E. (1993). Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin. Exp. Immunol. 91, 277-281.
19. Bhagat, K., & Vallance, P. (1995). Nitric oxide 9 years on. J. R. Soc. Med. 88, 667-673.
20. Bianchi, M., Ulrich. P., Bloom, O., Meistrell, M., Zimmerman, G.A., Schmidtmayerova, H., Bukrinsky, M., Donnelley, T., Bucala, R., Sherry, B., Manogue, K.R., Tortolani, A.J., Cerami, A., & Tracey, K.J. (1995). An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol. Med. 1, 254-266.
21. Billiar, T.R., Curran, R.D., Harbrecht, B.G., Stuehr, D.J., Demetris, A.J., & Simmons, R.L. (1990). Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate bio-synthesis while promoting hepatic damage. J. Leukoc. Biol. 48, 565-569.
22. Birgegard, G., & Caro, J. (1984). Increased ferritin synthesis and iron uptake in inflammatory mouse macrophages. Scand. J. Haematol. 33, 43-48.
23. Bogdan, C., Röllinghof, M., Vodovotz, Y., Xie, Q.-W., & Nathan, C. (1994). Regulation of inducible nitric oxide synthase in macrophages by cytokines and microbial products. In: Masihi, K.N., (Ed.), Immunotherapy of Infections. Marcel Dekker, Inc., New York, pp. 37-54.
24. Boje, K.M.K. (1996). Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res. 720, 75-83.
25. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., & Lipton, S.A. (1995). Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U.S.A. 92, 7162-7166.
26. Boughton-Smith, N.K., Evans, S.M., Hawkey, C.J., Cole, A.T., Balsitis, M., Whittle, N.J.R., & Moncada, S. (1993). Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 341, 338-340.
27. Boutard, V., Havouis, R., Fouqueray, B., Philippe, C., Moulinoux, J.P., & Baud, L. (1995). Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J. Immunol. 155, 2077-2084.
28. 2+-independent nitric oxide synthase activity in rat gastric mucosal cells. Eur. J. Pharmacol. 292, 111-114.
29. Bulut, V., Severn, A., & Liew, F.Y. (1993). Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem. Biophys. Res. Commun. 195, 1134-1138.
30. Burchiel, S.W., Hanson, K., & Warner, N.L. (1984). Clonal heterogenity of cyclic AMP responsivennes: A comparison of malignant murine lymphoid cell lines. Int. J. Immunopharmac. 6, 35-42.
31. Byrd, T., & Horwitz, M.A. (1989). Interferon gamma-activated human monocytes downregulate trensferrin receptors and inhibit the intracellular multiplication of Legionella pneumophilla by limiting the availability of iron. J. Clin. Invest. 83, 1457-1465.
32. Byrd, T., & Horwitz, M.A. (1991). Lactoferrin inhibits or promotes Legionella pneumophilla intracellular multiplication in non-activated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. J. Clin. Invest. 88, 1103-1112.
33. Byrne, G.I., Lehmann, L.K., & Landry, G.J. (1986). Induction of tryptophan catabolism in the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53, 347-351.
34. Capsoni, F., Minonzio, F., Ongari, A.M., Carbonelli, V., Galli, A., & Zanussi, C. (1995). IL-10 upregulates human monocyte phagocytosis in the presence of IL-4 and IFN-γ. J. Leukocyte Biol. 58, 351-358.
35. Cameron, M.L., Granger, D.L., Weinberg, J.B., Kozumbo, W.J., & Koren, H.S. (1990). Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am. Rev. Respir. Dis. 142, 1313.
36. Chamulitrat, W., Skrepnik, N.V., & Spitzer, J.J. (1996). Endotoxin-induced oxidative stress in the rat small intestine: role of nitric oxide. Shock 5, 217-222.
37. Chesrown, S.E., Monnier, J., Visner, G., & Nick, H.S. (1994). Regulation of inducible nitric oxide synthase mRNA levels by LPS, IFN-γ, TGF-β and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 200, 126-134.
38. Chun, S.Y., Eisenhauer, K.M., Kubo, M., & Hsueh, A.J. (1995). Interleukin-1 beta suppresses apoptosis in rat ovarian follicles by increasin nitric oxide production. Endocrinology 136, 3120-3127.
39. Cifone, M.G., Festuccia, C., Cironi, L., Cavallo, G., Chessa, M.A., Pensa, V., Tubaro, E., & Santoni, A. (1994). Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cell. Immunol. 157, 181-194.
40. Cobbs, C.S., Brenman, J.E., Aldape, K.D., Bredt, D.S., & Israel, M.A. (1995). Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55, 727-730.
41. Colasanti, M., Mollace, V., Cundari, E., Massoud, R., Nistico, G., & Lauro, G.M. (1993). The generation of nitric oxide participates in gamma IFN-induced MHC class II antigen expression by cultured astrocytoma cells. Int. J. Immunopharmac. 15, 763-771.
42. Conner, E.M., Chen, Y., & Grisham, M.B. (1995). Effect of nitric oxide synthase (NOS) inhibition on dextran sulfate sodium (DSS)-induced colitis in rats and mice. Gastroenterology 108, A801 (abstract).
43. Corradin, S.B., Fasel, N., Buchmüller-Rouiller, Y., Ransijn, A., Smith, J., & Mauël, J. (1993). Induction of macrophage nitric oxide production by interferon-g and tumor necrosis factor-a is enhanced by interleukin-10. Eur. J. Immunol. 23, 2045-2048.
44. Cox, G.W., Melillo, G., Chattopadhyay, U., Mullet, D., Fertel, R.H., & Varesio, L. (1992). Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol. 149, 3290-3296.
45. Croen, K.D. (1993). Evidence for an antiviral effect of nitric oxide: inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91, 2446-2452.
46. Cross, A.H., Misko, T.P., Rin, R.F., Hicket, W.F., Trotter, J.L., & Tilton, R.G. (1994). Aminoguanidine an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93, 2684-2690.
47. Cui, S., Reichner, J.S., Mateo, R.B., & Albina, J.E. (1994). Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54, 2462-2467.
48. Davidge, S.T., Baker, P.N., McLaughlin, M.C., & Roberts, J.M. (1995). Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ. Res. 77, 274-283.
49. Deakin, A.M., Payne, A.N., Wittle, B.J.R., & Moncada, S. (1995). The modulation of IL-6 and TNF-α release by nitric oxide following stimulation of J774 cells with LPS and IFN-γ. Cytokine 7, 408-416.
50. Decker, T., Lochmann-Matthes, M.-L., & Gifford, G. (1987). Cell associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138, 957-962.
51. De Groote, M.A., Fang, F.C. (1995). NO inhibitions: antimicrobial properties of nitric oxide. Clin. Infect. Dis. 21 (Suppl. 2), S162-S165.
52. Deguchi, M., Inaba, K., & Murumatsu, S. (1995). Counteracting effect of interferon-alpha and -beta on inrterferon-gamma-induced production of nitric oxide which is suppressive for antibody response. Immunol. Lett. 45, 157-162.
53. Ding, A.H., Nathan, C.F., & Stuehr, D.J. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141, 2407-2414.
54. Dong, Z., Staroselsky, A.H., Qi, X., Xie, K., & Fidler, I.J. (1994). Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 54, 789-793.
55. Drapier, J.-C., & Hibbs, J.B., Jr. (1988). Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 140, 2829-2838.
56. Drapier, J.-C., Wietzerbin, J., & Hibbs, J.B., Jr. (1988). Interferon-g and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 18, 587-1592.
57. Dueñas-Gonzales, A., Isales, C.M., del Mar Abad-Hernandez, M., Gonzales-Sarmiento, R., Sangueza, O., & Rodriguez-Commes, J. (1997). Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Modern Pathol. 10, 645-649.
58. Dumarey, C.H., Labrousse, V., Rastogi, N., Vargaftig, B.B., & Bachelet, M. (1994). Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J. Leukocyte Biol. 56, 36-40.
59. Durante, W., Kroll, M.H., Christodoulides, N., Peyton, K.J., & Schafer, A.I. (1997). Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. 80, 557-564.
60. Edwards, P., Cendan, J.C., Topping, D.B., Moldawer, L.L., Mackay, S., Copeland, E.M., & Lind, D.S. (1996). Tumor cell nitric oxide inhibits cell growth in vitro but stimulates tumorigenesis and experimental metastasis in vivo. J. Surg. Res. 63, 49-52.
61. Eichner, R.D., & Smeaton, T.C. (1983). Aggar accumulates in rat peritoneal macrophages elicited with thioglycolate broth. Scand. J. Immunol. 18, 259-263.
62. Eigler, A., Sinha, B., & Endres, S. (1993). Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem. Biophys. Res. Commun. 196, 494-501.
63. Eigler, A., Moeller, J., & Endres, S. (1995). Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J. Immunol. 154, 4048-4054.
64. Estevez, A.G., Radi, R., Barbeito, L., Shin, J.T., Thompson, J.A., & Beckman, J.S. (1995). Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65, 1543-1550.
65. Estrada, C., Gomez, C., Martin, C., Moncada, S., & Gonzales, C. (1992). Nitric oxide mediates tumor necrosis factor a cytotoxicity in endothelial cells. Biochem. Biophys. Res. Commun. 186, 475-482.
66. Farias-Eisner, R., Sherman, M.P., Aeberhardt, E., & Chaudhuri, G. (1994). Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. U.S.A. 91, 9407-9411.
67. Fedyk, E.R., Adawi, A., Looney, R.J., & Phipps, R.P. (1996). Regulation of IgE and cytokine production by cAMP: Implications for extrinsic asthma. Clin. Immunol. Immunopathol. 81, 101-113.
68. Fehsel, K., Kröncke, K.D., Meyer, K.L., Huber, H., Wahn, V., & Kolb-Bachofen, V. (1995). Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155, 2858-2865.
69. Fischer-Stenger, K., & Marciano-Cabral, F. (1992). The arginine-dependent cytolytic mechanism plays a role in destruction of Naegleria fowleri amoebe by activated macrophages. Infect. Immun. 60, 5126-5131.
70. Förstermann, U., Gath, I., Schwarz, P., Closs, E.I., & Kleinert, H. (1995). Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem. Pharmacol. 50, 1321-1332.
71. Fouqueray, B., Boutard, V., Philippe, C., Kornreich, A., Marchant, A., Perez, J., Goldman, M., & Baud, L. (1995). Mesangial cell-drived interleukin-10 modulates cell response to lipopolysaccharide. Am. J. Pathol. 147, 176-182.
72. ω-nitro-L-arginine methyl ester) in a murine sepsis model. Arch. Surg. 130, 410-414.
73. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol. Chem. Hoppe-Seyler 373, 897-902.
74. Garg, U.T., & Hassid, A. (1989a). Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83, 1744-1777.
75. Garg, U.C., & Hassid, A. (1989b). Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am. J. Physiol. 257, F60-F66.
76. Garg, U.C., Devi, L., Turndorf, H., Goldfrank, L.R., & Bansinath, M. (1992). Effect of nitric oxide on mitogenesis and proliferation of cerebellar glial cells. Brain Res. 592, 208-212.
77. Gazzinelli, R.T., Oswald, I.P., James, S.L., & Sher, A. (1992). IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148, 1792-1796.
78. Geng, Y., Hansson, G.K., & Holme, E. (1992). Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ. Res. 71, 1268-1276.
79. Geng, Y.-J., Hellstrand, K., Wennmalm, A., & Hansson, G.K. (1996). Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to γ-interferon and tumor necrosis factor-α. Cancer Res. 56, 866-874.
80. Goureau, O., Lepoivre, M., Becquet, F., & Curtois, Y. (1993). Differential regulation of inducible nitric oxide synthase by fibroblast growth factor and trans-forming growth factor-β in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation. Proc. Natl. Acad. Sci. U.S.A. 90, 4276-4280.
81. Green, S.J., Meltzer, M.S., Hibbs, J.B., Jr., & Nacy, A. (1990). Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144, 278-283.
82. Grisham, M.B., Specian, R.D., & Zimmerman, T.E. (1994). Effects of nitric oxide synthase inhibition on the patho-physiology observed in a model of chronic granulomatous colitis. J. Pharmacol. Exp. Ther. 271, 1114-1121.
83. Guillemard, E., Geniteau-Legendre, M., Kergot, R., Lemaire, G., Petit, J.-F., Labarre, C., & Querro, A.M. (1996). Activity of nitric oxide-generating compounds against encephalomyocarditis virus. Antimicrob. Agents Chemother. 40, 1057-1059.
84. Guo, F.H., Uetani, K., Haque, S.J., Williams, B.R.G., Dweik, R.A., Thunnissen, F.B.J.M., Calhoun, W., & Erzurum, S.C. (1997). Interferon γ and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J. Clin. Invest. 100, 829-838.
85. Habib, A., Bernard, C., Lebret, M., Créminon, C., Espositi, B., Tedgui, A., & Maclouf, J. (1997). Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J. Immunol. 158, 3845-3851.
86. Hadden, J.W., & Coffey, R.G. (1990). Early events in T lymphocyte activation by mitogens. Immunopharmacol. Rev. 1, 273-376.
87. Harbrecht, B.G., Billiar, T.R., Stadler, J, Demetris, A.J., Ochoa, J., Curran, R.D., & Simmons, R.L. (1992). Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J. Leukoc. Biol. 52, 390-394.
88. Harris, N., Buller, M.L., & Karupiah, G. (1995). Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69, 910-915.
89. Hartung, H.-P., Jung, S., Stoll, G., Zielasek, J., Schmidt, B., & Archelos, J.J. (1992). Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40, 197-210.
90. Hasegawa, H., Satake, Y., & Kobayashi, Y. (1990). Effect of cytokines on Japanese encephalitis virus production by human monocytes. Microbiol. Immunol. 34, 459-466.
91. Hassid, A., Arabshahi, H., Bourcier, T., Dhaunsi, G.S., & Matthews, C. (1994). Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells. Am. J. Physiol. 267, H1040-H1048.
92. Haswell-Elikns, M.R., Satarug, S., Tsuda, M., Mairiang, E., Esumi, H., Sithitaworn, P., Mairiang, P., Saitoh, M., Yongvanit, P., & Elkins, D.B. (1994). Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis. Mutat. Res. 305, 241-252.
93. ω-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase. Br. J. Pharmacol. 121, 395-400.
94. Hey, C., Wessler, I., & Racké, K. (1995). Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages., with a concomitant reduction in arginase activity. Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 651-659.
95. Hibbs, J.B., Vavrin, Z., & Taintor, R.R. (1987). L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138, 550-565.
96. Higuchi, M., Higashi, N., Taki, H., & Osawa, T. (1990). Cytolytic mechanisms of activated macrophages. Tumor necosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. J. Immunol. 144, 1425-1431.
97. Hirokawa, K., O'Shaugnessy, K., Moore, K., Ramrakha, P., & Wilkins, M.R. (1994). Induction of nitric oxide synthase in cultured smooth muscle cells: the role of cyclic AMP. Br. J. Pharmacol. 112, 396-402.
98. Hock, C.E., Yin, K., Yue, G., & Wong, P.Y.-K. (1997). Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am. J. Physiol. 272, H843-H850.
99. Hoffman, R.A., Zhang, G., Nussler, N.C., Gleixner, S.L., Ford, H.R., Simmons, R.L., & Watkins, S.C. (1997). Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am. J. Physiol. 272, G383-G392.
100. Hogaboam, C.M., Jacobson, K., Collins, S.M., & Blennerhassett, M.G. (1995). The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am. J. Physiol. 268, G673-G684.
101. Hooper, D.C., Ohnishi, S.T., Kean, R., Numagami, Y., Dietzschold, B., & Koprowski, H. (1995). Local nitric oxide production in viral and auto-immune diseases of the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 92, 5312-5316.
102. Ichinose, Y., Bakouche, O., Tsao, J.Y., & Fidler, I.J. (1988). Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both. J. Immunol. 141, 512-518.
103. Imai, T., Hirata, Y., Kanno, K., & Marumo, F. (1994). Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 93, 543-549.
104. Ito, M., Watanabe, M., Kamiya, H., & Sakutari, M. (1996). Inhibition of natural killer cell activity against cyto-megalovirus-infected fibroblasts by nitric oxide-releasing agents. Cell. Immunol. 174, 13-18.
105. luvone, T., D'Acquisto, F., Carnuccio, R., & Di Rosa, M. (1996). Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo. Life Sci. 59, PL209-PL211.
106. James, S.L. (1995). Role of nitric oxide in parasitic infections. Microbiol. Rev. 59, 533-547.
107. James, J.L., Cook, K.W., & Lazdins, J.K. (1990). Activation of human monocyte-derived macrophages to kill sch-istosomula of Schistosoma mansoni in vitro. J. Immunol. 145, 2686-2690.
108. Jungi, T.W., Brcic, M., Sager, H., Dobbelaere, D.A.E., Furger, A., & Roditi, I. (1997). Anatagonistic effects of IL-4 and interferon-gamma (IFN-γ) on inducible nitric oxide synthase expression in bovine macrophages exposed to Gram-positive bacteria. Clin. Exp. Immunol. 109, 431-438.
109. Juretic, A., Spagnoli, G.C., von Bremen, K., Horig, H., Filgueira, L., Luscher, U., Babst, R., Harder, F., & Heberer, M. (1994). Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide dependent. Cell. Immunol. 157, 462-477.
110. Kamijo, R., Shapiro, D., Le, J., Huang, S., Aguet, M., & Vilèek, J. (1993). Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon g receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 6626-6630.
111. Kaneto, H., Fujii, J., Seo, H.G., Suzuki, K., Matsuoka, T., Nakamura, M., Tatsumi, H., Yamasaki, Y., Kamada, T., & Taniguchi, N. (1995). Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44, 733-738.
112. Kankaanranta, H., Knowles, R.G., Vuorinen, P., Kosonen, O., Holm, P., & Moilanen, E. (1997). 3-Morpholino-sydnonimine-induced suppression of human neutrophil degranulation is not mediated by cyclic GMP, nitric oxide or peroxynitrite: inhibition of the increase in intracellular free calcium concentration by N-morpholino-iminoacetonitrile, a metabolite of 3-morpholino-sydnonimine. Mol. Pharmacol. 51, 882-888.
113. Karupiah, G., & Harris, N. (1995). Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J. Exp. Med. 181, 2171-2179.
114. Karupiah, G., Xie, Q.-w., Mark, R., Buller, L., Nathan, C., Durate, C., & MacMicking, J.D. (1993). Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 266, 1445-1448.
115. Keller, R., Geiges, M., & Keist, R. (1990). L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macro-phages. Cancer Res. 50, 1421-1425.
116. Ketteler, M., Border. W.A., & Noble, N.A. (1994). Cytokines and L-arginine in renal injury and repair. Am. J. Physiol. 267, F197-F207.
117. Kilbourn, R.G., Szabó, C., & Traber, D.L. (1997). Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7, 235-246.
118. Klatt, P., Schmidt, K., & Mayer, B. (1992). Brain nitric oxide synthase is a haemoprotein. Biochem. J. 288, 15-17.
119. Klostergaard, J., Leroux, M.E., & Hung, M.-C. (1991). Cellular models of macrophage tumoricidal effector mechanisms in vitro: Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro. J. Immunol. 147, 2802-2808.
120. Koide, M., Kawahara, Y., Nakayama, I., Tsuda, T., & Yokoyama, M. (1993). Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. J. Biol. Chem. 268, 24959-24966.
121. Kolb, J.P., Paul-Eugene, N., Damais, C., Abadie, A., Yamaoka, K., Drapier, J.C., & Dugas, B. (1994). IL-4 stimulates cGMP production in normal IFN-γ-activated human monocytes. Involvement of the L-arginine pathway. J. Biol. Chem. 269, 9811-9817.
122. Konturek, S.J., Brzozowski, T., Majka, J., Pytko-Polonczyk, J., & Stachura, J. (1993). Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur. J. Pharmacol. 239, 215-217.
123. Koprowski, H., Zheng, Y.M., Heber-Katz, E., Fraser, N., Rorke, L., Fu, Z.F., Hanlon, C., & Dietzschold, B. (1993). In vivo expression of inducible nitric oxide synthase in experimentally induced neurological disease. Proc. Natl. Acad. Sci. U.S.A. 90, 3024-3027.
124. Kreil, T.R., & Eibl, M.M. (1996). Nitric oxide and viral infection: No antiviral activity against a flavivirus 'in vitro'. Virology 219, 304-306.
125. Kriegbaum, H., Benninghoff, B., Hacker-Shahin. B., & Droge, W. (1987). Correlation of immunogenicity and production of ornithine by peritoneal macrophages. J. Immunol. 139, 899-904.
126. Kubes, P. (1993). Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am. J. Physiol. 264, G143-G149.
127. Kubes, P., Sihota, E., & Hickey, M.J. (1997). Endogenous but not exogenous nitric oxide decreases TNF-α-induced leukocyte rolling. Am. J. Physiol. 273, G628-G635.
128. Lamarque, D., & Whittle, B.J.R. (1995). Involvement of superoxide and xanthine oxidase in neutrophil-independent rat gastric damage induced by NO donors. Br. J. Pharmacol. 116, 1843-1848.
129. Landino, L.M., Crews, B.C., Timmons, M.D., Morrow, J.D., & Marnett, L.J. (1996). Peroxynitrite, the coupling product of nitric oxide and super-oxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 93, 15069-15074.
130. Lane, T.E., Wu, B.A., & Howard, D.H. (1991). Iron limitation and the gamma-interferon-mediated antihistoplasma state of murine macrophages. Infect. Immun. 59, 2274-2278.
131. Lane, T.E., Paoletti. A.D., & Buchmeier, M.J. (1997). Dissociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine corona-virus. J. Virol. 71, 2202-2210.
132. Laubach, V.E., Shesely, E.G., Smithies, O., & Sherman, P.A. (1995). Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. U.S.A. 92, 10688-10692.
133. Lee, S.H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., & Hwang, D. (1992). Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopoly-saccharide. J. Biol. Chem. 267, 25934-25938.
134. Leijh, P.C., van Zwet, T.L., ter Kuile, M.N., & van Furth, R. (1984). Effect of thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages. Infect. Immun. 46, 448-452.
135. Li, L., Kilbourne, R.G., Adams, J., & Fidler, I.J. (1991). Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res. 51, 2531-2535.
136. Liaudet, L., Gnaegi, A., Rosselet, A., Markert, M., Boulat, O., Perret, C., & Feihl, F. (1997). Effect of L-lysine on nitric oxide overproduction in endotoxic shock. Br. J. Pharmacol. 122, 742-748.
137. Liew, F.Y., Li, Y., & Millott, S. (1990). Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145, 4306-4310.
138. h1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21, 2489-2494.
139. Lin, R.T., Lin, T.S., Tilton, R.G., & Cross, A.H. (1993). Nitric oxide localized to spinal cords of mice with experimental autoimmune encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178, 643-648.
140. Lin, K.T., Xue, J.Y., Nomen, M., Spur, B., & Wong, P.Y. (1995). Peroxynitrite-induced apoptosis in HL-60 cells. J. Biol. Chem. 270, 16487-16490.
141. Lind, D.S., Copeland, E.M., & Souba, W.W. (1993). Endotoxin stimulates arginine transport in pulmonary endothelial cells. Surgery 114, 199-205.
142. Liu, R.H., Jacob, J.R., Hotchkiss, J.H., Cote, P.J., Gerin, J.L., & Tennant, B.C. (1994). Woodchuck hepatitis virus surface antigen induces nitric oxide synthesis in hepatocytes: possible role of hepatocarcinogenesis. Carcinogenesis 15, 2875-2877.
143. Liu, R.H., Jacob, J.R., Hotchkiss, J.H., & Tennant, B.C. (1993). Synthesis of nitric oxide and nitrosamine by immortalized woodchuck hepatocytes. Carcinogenesis 14, 1609-1613.
144. López-Guerrero, J.A., & Alonso, M.A. (1997). Nitric oxide production induced by herpes simplex virus type 1 does not alter the course of the infection in human monocytic cells. J. Gen. Virol. 78, 1977-1980.
145. López-Guerrero, J.A., Rayet, B., Tuynder, M., Rommelaere, J., & Dinsart, C. (1997). Constitutive activation of U937 promonocytic cell clones selected for their resistance to parvovirus H-1 infection. Blood 89, 1642-1653.
146. Lorsbach, R.B., Murphy, W.J., Lowenstein, C.J., Snyder, S.H., & Russell, S.W. (1993). Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-g and lipopolysaccharide. J. Biol. Chem. 68, 1908-1913.
147. Ludowyk, P.A., Hughes, W., Hugh, A., Willenborg, D.O., Rockett, K.A., & Parish, C.R. (1993). Astrocytic hypertrophy: An important pathological feature of chronic experimental encephalitic in aged rats. J. Neuroimmunol. 48, 121-134.
148. Lundberg, J.O., Hellstrom, P.M., Lundberg, J.M., & Alving, K. (1994). Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 344, 1673-1674.
149. Maciejewski, J.O., Selleri, C., Sato, T., Cho, H.J., Keefer, L.K., Nathan, C.F., & Young, N.S. (1995). Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J. Clin. Invest. 96, 1085-1092.
150. MacMicking, J.D., Willenborg, D.O., Weidemann, M.J., Rockett, K.A., & Cowden, W.B. (1992). Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory cytokines in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176, 303-307.
151. MacMicking, J.D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D.S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., Chen, H., & Mudgett, J.S. (1995). Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641-650.
152. Marotta, P., Sautebin, L., & Di Rosa, M. (1992). Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774.2 cells. Br. J. Pharmacol. 107, 640-641.
153. Mateo, R.B., Reichner, J.S., & Albina, J.E. (1996). NO is not sufficient to explain maximal cytotoxicity of tumoricidal macrophages against an NO-sensitive cell line. J. Leukoc. Biol. 60, 245-252.
154. Matthews, J.S., McWilliams, P.J., Key, B.J., & Keen, M. (1995). Inhibition of prostacyclin release from cultured endothelial cells by nitrovasodilator drugs. Biochim. Biophys. Acta 1269, 237-242.
155. Mautino, G., Paul-Eugene, N., Chanez, P., Vignola, A.M., Kolb, J.P., Bousquet, J., & Dugas, B. (1994). Heterogenous spontaneous and interleukin-4 induced nitric oxide production by human monocytes. J. Leukoc. Biol. 56, 15-20.
156. Mavier, P., & Edgington, T.S. (1984). Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism. J. Immunol. 132, 1980-1987.
157. Mayer, B., Schrammel, A., Klatt, P., Koesling, D., & Schmidt, K. (1995). Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase: Dependence on glutathione and possible role of S-nitrosation. J. Biol. Chem. 270, 17355-17360.
158. McCafferty, D.-M., Mudgett, J.S., Swain, M.G., & Kubes, P. (1997). Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 112, 1022-1027.
159. Mebmer, U.K., Ankarcrona, M., Nicotera, P., & Brune, B. (1994). p53 expresssion in nitric oxide-induced apoptosis. FEBS Lett. 355, 23-26.
160. Melkova, Z., & Esteban, M. (1994). Interferon-γ severely inhibits DNA synthesis of vaccinia virus in a macrophage cell line. Virology 198, 731-765.
161. Melkova, Z., & Esteban, M. (1995). Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J. Immunol. 155, 5711-5718.
162. Middleton, S.J., Shorthouse, M., & Hunter, J.O. (1993). Increased nitric oxide synthesis in ulcerative colitis. Lancet 341, 465-466.
163. Milano, S., Arcoleo, F., D'Agostino, P., & Cillari, E. (1997). Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob. Agents. Chemother. 41, 117-121.
164. Miller, M.J.S., Sadowska-Krowicka, H., Chotinaruemol, S., Kakkis, J.L., & Clark, D.A. (1992). Amelioration of chronic ileitis by nitric oxide synthase inhibition. J. Pharmacol. Exp. Ther 264, 11-16.
165. Miller, M.J.S., Chotinaruemol, S., Sadowska-Krowicka, H., Kakkis, J.L., Munshi, U.K., Zhang, X.-J., & Clark, D.A. (1993). Nitric oxide: Jekyll and Hyde of gut inflammation. Agents Actions 39, C180-C182.
166. Mills, C.D., Shearer, J., Evans, R., & Caldwell, M.D. (1992). Macrophage arginine metabolism and inhibition of stimulation of cancer. J. Immunol. 149, 2709-2714.
167. Minghetti, L., Polazzi, E., Nicolini, A., Créminon, C., & Levi, G. (1996). Interferon g and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J. Neurochem. 66, 1963-1970.
168. Minnard, E.A., Shou, J., Naama, H., Cech, A., Gallagher, H., & Daly, J.M. (1994). Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch. Surg. 129, 142-148.
169. Minoura, T., Takata, T., Sakaguchi, M., Takada, H., Yamamura, M., Hioki, K., & Yamamoto, M. (1988). Effect of dietary eicosapentaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Res. 48, 4790-4794.
170. Mitrovic, B., Ignarro, L.J., Vinters, H.V., Akers, M.A., Schmid, I., Uittenbogaart, C., & Merill, J.E. (1995). Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65, 531-539.
171. Miyazaki, M., Wahid, S., Bai, L., & Namba, M. (1992). Effects of intracellular cyclic AMP and cyclic GMP levels on DNA synthesis of young-adult rat hepatocytes in primary culture. Exp. Cell Res. 200, 404-409.
172. Mordan, L.J., Burnett, T.S., Zhang, L.-X., Tom, J., & Cooney, R.V. (1993). Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis 14, 1555-1559.
173. Modolell, M., Corraliza, I.M., Link, F., Soler, G., & Eichmann, K. (1995). Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25, 1101-1104.
174. Modolell, M., Munder, M., Corraliza, I.M., Eichman, K., & Soler, G. (1996). Arginase and NO-synthase expression represent two alternative activation stages of murine macrophages. J. Lekoc. Biol., Supplement 1996: 57, Abstract 264.
175. Morga, E., & Heuschling, P. (1996). Interleukin-4 down-regulates MHC class II antigens on cultured rat astrocytes. Glia 17, 175-179.
176. Morris, S.M., Jr. (1992). Regulation of enzymes of urea and arginine synthesis. Nutrition 12, 81-101.
177. Mourelle, M., Vilaseca, J., Guarner, F., Salas, A., & Malagelada, J.-R. (1996). Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am. J. Physiol. 270, G425-G430.
178. Mullet, D., Fertel, R.H., Kniss, D., & Cox, G.W. (1997). An increase in inracellular cyclic AMP modulates nitric oxide production in IFN-γ-treated macrophages. J. Immunol. 158, 897-904.
179. Muñoz-Fernández, M. A., Fernández, M.A., & Fresno, M. (1992). Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and LPS through an nitric oxide-dependent mechanism. Immunol. Lett. 33, 35-40.
180. Muñoz-Fernández, M.A., & Fresno, M. (1993). Involvement of nitric oxide on the cytokine induced growth of glial cells. Biochem. Biophys. Res. Commun. 194, 319-325.
181. Nagase, S., Takemura, K., Ueda, A., Hirayama, A., Aoyagi, K., Kondoh, M., & Koyama, A. (1997). A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine. Biochem. Biophys. Res. Commun. 233, 150-153.
182. Nathan, C.F. (1992). Nitric oxide as a scretory product of mammalian cells. FASEB J. 6, 3051-3064.
183. Nathan, C.F., & Hibbs, J.B. (1991). Role of nitric oxide synthesis in macro-phage antimicrobial activity. Curr. Opin. Immunol 3, 65-70.
184. Neuzil, J., & Stocker, R. (1993). Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett. 331, 281-284.
185. Newby, A.C., Southgate, K.M., & Assender, J.W. (1992). Inhibition of vascular smooth muscle cell proliferation by endothelium-dependent vasodilators. Herz 17, 291-299.
186. Nishida, K., Harrison, D.G., Navas, J.P., Fisher, A.A., Dockery, S.P., Uematsu, M., Nerem, R.M., Alexander, R.W., & Murphy, T.J. (1992). Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90, 2092-2096.
187. Nunokawa, Y., & Tanaka, S. (1992). Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem. Biophys. Res. Commun. 188, 409-415.
188. Ohata, T., Fukuda, K., Takahashi, M., Sugimura, T., & Wakabayashi, K. (1997). Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by ω3 polyunsaturated fatty acids. Jpn. J. Cancer Res. 88, 234-237.
189. Ohshima, H., & Bartsch, H. (1994). Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305, 253-264.
190. Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., & Sakoda, S. (1995). Expression of the inducible nitric oxide synthase in the central nervous system of mice correlartes with the severity of actively induced experi-mental allergic encephalomyelitis. J. Neuroimmunol. 62, 103-112.
191. Oswald, I.P., Afroun, S., Bray, D., Petit, J.-F., & Lamaire, G. (1992a). Low response of BALB/c macrophages to priming and activation signals. J. Leukoc. Biol. 52, 315-322.
192. Oswald, I.P., Wynn, T.A., Sher, A., & James, S.L. (1992b). Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor a required as a costimulatory factor for interferon-γ-induced activation. Proc. Natl. Acad. Sci. U.S.A. 89, 8676-8680.
193. Padgett, E.L., P& ruett, S.B. (1992). Evaluation of nitrite production by human monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 186, 775-781.
194. Paietta, E., & Schwarzmeier, J.D. (1983). Differences in beta-adrenergic receptor density and adenylate cyclase activity between normal and leukaemic leukocytes. Eur. J. Clin. Invest. 13, 339-346.
195. Paul, R.J. (1989). Smooth muscle energetics. Annu. Rev. Physiol. 54, 331-349.
196. Paul, A., Bryant, C., Lawson, M.F., Chilvers, E.R., & Plevin, R. (1997). Dissociation of lipopolysaccharide-mediated induction of nitric oxide synthase and inhibition of DNA synthesis in RAW 264.7 macrophages and rat aortic smooth muscle cells. Br. J. Pharmacol. 120, 1439-1444.
197. Pegg, A.E. (1988). Polyamine metabolism and its importance in neoplastic growth and as target for chemotherapy. Cancer Res. 48, 759-774.
198. Perretti, M., Szabo, C., & Thiemermann, C. (1995). Effect of interleukin-4 and inter-leukin-10 on leucocyte migration and nitric oxide production in the mouse. Br. J. Pharmacol. 116, 2251-2257.
199. Peterson, D.A., Peterson, D.C., Archer, S., & Weir, E.K. (1992). The non-specificity of specific nitric oxide synthase inhibitors. Biochem. Biophys. Res. Commun. 187, 797-801.
200. Pfefferkorn, E.R. (1984). Interferon g blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cell to degrade tryptophan. Proc. Natl. Acad. Sci. U.S.A. 81, 908-912.
201. Pfeiffer, C.J., & Qiu, B.S. (1995). Effects of chronic nitric oxide synthase inhi-bition on TNB-induced colitis in rats. J. Pharm. Pharmacol. 47, 827-832.
202. Phipps, R.O., Stein, S.H., & Roper, R.L. (1991). A new view of prostaglandin E regulation of the immune response. Immunol. Today 12, 349-352.
203. Pietraforte, D., Tritarelli, E., Testa, U., & Minetti, M. (1994). gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leukoc. Biol. 55, 175-182.
204. Pipili-Synetos, E., Papageorgiu, A., Sakkoula, E., Sotiropoulou, G., Fotsis, T., Karkioulakis, G., & Maragoudakis, M.E. (1995). Inhibition of angio-genesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J. Pharmacol. 116, 1829-1834.
205. Poli, G., Kinter, A.L., Justement, J.S., Kehrl, J.H., Bressler, P., Stanley, S., & Fauci, A.S. (1990). Tumor necrosis factor a functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. U.S.A. 87, 782-785.
206. Potter, J.D. (1996). Nutrition and colorectal cancer. Cancer Causes Control 7, 127-146.
207. Punjabi, C.J., Laskin, D.L., Heck, D.E., & Laskin, J.D. (1992). Production of nitric oxide by murine bone marrow cells. Inverse correlation with cellular proliferation. J. Immunol. 149, 2179-2184.
208. Rachmilewitz, D., Stamler, J.S., Bachwich, D., Karmeli, F., Ackerman, Z., & Podolsky, D.K. (1995a). Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36, 718-723.
209. Rachmilewitz, D., Karmeli, F., Okon, E., & Bursztyn, M. (1995b). Experimental colitis is ameliorated by inhibition by nitrix oxide synthase activity. Gut 37, 247-255.
210. Radomski, M.W., Palmer, R.M., & Moncada, S. (1990). An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. U.S.A. 87, 5193-5197.
211. Ribbons, K.A., Thompson, J.H., Liu, X., Pennline, K., Clark, D.A., & Miller, M.J.S. (1997). Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur. J. Pharmacol. 323, 245-254.
212. Robertson, F.M., Offner, P.J., Ciceri, D.P., Becker, W.K., & Pruitt, B.A. (1994). Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch. Surg. 129, 149-156.
213. Rojas, A., Padron, J., Caveda, L., Palacios, M., & Moncada, S. (1993). Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lipopolysaccharide. Biochem. Biophys. Res. Commun. 191, 441-446.
214. Rolph, M.S., Ramshaw, I.A., Rockett, K.A., Ruby, J., & Cowden, W.B. (1996a). Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology 217, 470-477.
215. Rolph, M.S., Cowden, W.B., Medveczky, C.J., & Ramshaw, I.A. (1996b). A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. J. Virol. 70, 7678-7685.
216. Rosbe, K.W., Prazma, J., Petrusz, P., Mims, W., Ball, S.S., & Weissler, M.C. (1995). Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinima of the head and neck. Otolaryngol. Head Neck Surg. 113, 541-549.
217. Ruetten, H., Southan, G.J., Abate, A., & Thiemermann, C. (1996). Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br. J. Pharmacol. 118, 261-270.
218. Ruuls, S.R., Van der Linden, S., Sontrop, K., Huitinga, I., & Dijkstra, C.D. (1996). Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103, 467-474.
219. 2 and to L-arginine dependent system in murine macrophages. Microbiol. Immunol. 35, 325-329.
220. Sakkoula, E., Pipili-Synetos, E., & Maragoudakis, M.E. (1997). Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2. Br. J. Pharmacol. 122, 793-795.
221. Salgo, M.G., Squadrito, G.L., & Pryor, W.A. (1995). Peroxynitrite causes apoptosis in rat thymocytes. Biochem. Biophys. Res. Commun. 215, 1111-1118.
222. +2-independent nitric oxide synthases. FEBS Lett. 291, 145-149.
223. Salvemini, D., Misko, T.P., Masferrer, J.L., Seibert, K., Currie, M.G., & Needleman, P. (1993). Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U.S.A. 90, 7240-7244.
224. Salvemini, D., Seibert, K., Masferrer, J.L., Misko, T.P., Currie, M.G., & Needleman, P. (1994). Endogenous nitric oxide enhances prosta-glandin production in a model of renal inflammation. J. Clin. Invest. 93, 1940-1947.
225. Salzman, A.L. (1995). Nitric oxide in the gut. New Horizons 3, 352-364.
226. Sarih, M., Souvannavong, V., & Adam, A. (1993). Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 191, 503-508.
227. Sato, H., Ishii, T., Sugita, Y., & Bannai, S. (1991). Induction of cationic amino acid transport activity in mouse peritoneal macrophages by lipopoly-saccharide. Biochem. Biophys. Acta 1069, 46-52.
228. Sato, H., Fujiwara, M., & Bannai, S. (1992). Effect of lipopolysacharide on transport and metabolism of arginine in mouse peritoneal macrophages. J. Leukoc. Biol. 52, 161-164.
229. Sato, K., Miyakawa, K., Takeya, M., Hattori, R., Yui, Y., Sunamoto, M., Ichimori, Y., Ushi, Y., & Takahashi, K. (1995). Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat iNOS. J. Leukoc. Biol. 57, 36-44.
230. Sautebin, L., Ialenti, A., Ianaro, A., & Di Rosa, M. (1995). Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br. J. Pharmacol. 114, 323-328.
231. Schneemann, M., Schoedon, G., Hofer, S., Blau, N., Guerrero, L., & Schaffner, A. (1993). Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononoclear phagocytes. J. Infect. Dis. 167, 1358-1363.
232. Schneider, E., & Dy, M. (1985). The role of arginase in the immune response. Immunol. Today 6, 136-139.
233. Schneider, E., Ihle, J.N., & Dy, M. (1985). Homogenous interleukin 3 enhances arginase activity in murine hematopoietic cells. Lymphokine Res. 4, 95-102.
234. Schultz, P.J., & Raij, L. (1992). Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J. Clin. Invest. 90, 1718-1725.
235. 2+-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105, 575-580.
236. Scott, G.S., Williams, K.I., & Bolton, C. (1996). A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis. Inflamm. Res. 45, 524-529.
237. Scioratti, C., Nistico, G., Meldolesi, J.,& Clementi, E. (1997). Nitric oxide effects cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic-independent slowing of cell cycling. Br. J. Pharmacol. 122, 687-697.
238. Sessa, W.C., Hecker, M., Mitchell, J.A., & Vane, J.R. (1990). The metabolism of L-arginine and its significance for the biosythesis of endothelium-derived relaxing factor: L-glutamine inhibits generation of L-arginine by cultured endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 87, 8607-8611.
239. Shimaoka, M., Iida, T., Ohara, A., Taenaka, N., Mashimo, T., Honda, T., & Yoshiya, I. (1995). NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem. Biophys. Res. Commun. 209, 519-526.
240. Shemer, Y., Wallach, D., & Sarov, I. (1989). Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon. Infect. Immun. 57, 3484-3490.
241. Sicher, S.C., Vazquez, M.A., & Lu C.Y. (1994). Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153, 1293-1300.
242. Sivo, J., & Vogel, S.N. (1996). IL-10 differentially regulates mRNA expression induced by lipopolysaccharide and interferons in murine peritoneal macrophages. J. Endotoxin Res. 3, 407-414.
243. Skinner, M., & Marbrook, J. (1987). The most efficient cytotoxic T lymphocytes are the least susceptible to lysis. J. Immunol. 139, 985-987.
244. Sonoki, T., Nagasaki, A., Gotoh, T., Takiguchi, M., Takeya, M., Matsuzaki, M., & Mori, M. (1997). Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J. Biol. Chem. 272, 3689-3693.
245. Stadler, J., Billiar, T.R., Curran, R.D., Stuehr, D.J., Ochoa, J.B., & Simmons, R.L. (1991). Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. 260, C910-C916.
246. Stadler, J., Habrecht, B.G., Di Silvio, M., Curran, R.D., Jordan, M.L., Simmons, R.L., & Billiar, T.R. (1993). Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by Kupffer cells. J. Leukoc. Biol. 53, 165-172.
247. Stocker, R., Yamamoto, Y., McDonagh, A.F., Gazer, A.N., & Ames, B.N. (1987). Bilirubin is an antioxidant of possible physiologic importance. Science 235, 1043-1046.
248. Stuehr, D.J., & Marletta, M.A. (1985). Mammalian nitrate biosynthesis: mouse macropahges produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 82, 7738-7742.
249. Stuehr, D.J., & Nathan, C.F. (1989). Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169, 1543-1555.
250. Summersgill, J.T., Powell, L.A., Buster, B.L., Miller, R.D., & Ramirez, J.A. (1992). Killing of Legionella pneumophila by nitric oxide in γ-interferon-activated macrophages. J. Leukoc. Biol. 52, 625-629.
251. Sütö, T., Losonczy, G., Qiu, C., Hill, C., Samsell, L., Ruby, J., Charon, N., Venute, R., & Baylis, C. (1995). Acute changes in urinary excretion of nitrite +nitrate do not necessarily predict renal vascular NO production. Kid. Int. 48, 1272-1277.
252. Swierkosz, T.A., Mitchell, J.A., Warner, T.D., Botting, R.M., & Vane, J.R. (1995). Coinduction of nitric oxide synthase and cyclooxygenase: intercations between nitric oxide and prostanoids. Br. J. Pharmacol. 114, 1335-1342.
253. Szabó, C. (1996). The pathophysiological role of peroxynitrite in shock, inflammation and ischemia-reperfusion injury. Shock 6, 79-88.
254. Szabó, C., Mitchell, J.A., Thiemermann, C., & Vane, J.R. (1993). Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108, 786-789.
255. Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N., & Kishimoto, T. (1995). Targeted disruption of the NF-IL6 gene discloses its essential role in bacterial killing and tumor cytotoxicity by macrophages. Cell 80, 353-361.
256. Tepperman, B.L., Brown, J.F., & Whittle, B.J.R. (1993). Nitric oxide induction and intestinal epithelial cell viability in rats. Am. J. Physiol. 265, G214-G218.
257. Terenzi, F., Diaz-Guerra, M.J.M., Casado, M., Hortelano, S., Leoni, S., & Bosca, L. (1995). Bacterial lipopeptides induce nitric oxide synthase and promote apoptosis through nitric oxide-independent pathways in rat macrophages. J. Biol. Chem. 270, 6017-6021.
258. Tetsuka, T., Daphna-Iken, D., Srivastava, S.K., Baier, L.D., Dumaine, J., & Morrison, A.R. (1995). Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc. Natl. Acad. Sci. U.S.A. 91, 12168-12172.
259. Tetsuka, T., Daphna-Iken, D., Miller, B.W., Guan, Z., Baier, L.D., & Morrison, A.R. (1996). Nitric oxide amplifies interleukin 1-induced cyclooxy-genase-2 expression in rat mesangial cells. J. Clin. Invest. 97, 2051-2056.
260. Thiemermann, C., & Vane, J. (1990). Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182, 591-595.
261. Thomsen, L.L., Baguley, B.C., & Wilson, W.R. (1992). Nitric oxide: its product-ion in host cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid. Cancer Chemother. Pharmacol. 31, 151-155.
262. Thomsen, L.L., Lawton, F.G., Knowles, R.G., Beesley, J.E., Riveros-Moreno, V., & Moncada, S. (1994). Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 54, 1352-1354.
263. Thomsen, L.L., Milles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G., & Moncada, S. (1995). Nitric oxide synthase activity in human brest cancer. Br. J. Cancer 72, 41-44.
264. Thomsen, L.L., Scott, J.M.J., Topley, P., Knowles, R.G., Keerie, A.-J., & Frend, A.J. (1997). Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57, 3300-3304.
265. Tiao, G.R.J., & Ogle, C. (1994). Detrimental effects of nitric oxide synthase inhibition may be caused by high levels of tumor necrosis factor and interleukin 6. Surgery 116, 332-338.
266. Uppu, R.M., Squadrito, G.L., & Pryor, W.A. (1996). Acceleration of peroxy-nitrite oxidations by carbon dioxide. Arch. Biochem. Biophys. 327, 335-343.
267. Verdot, L., Lalmanach, G., Vercruysses, V., & Hartman, S. (1996). Cystatins upregulate nitric oxide release from interferon-γ-activated mouse peritoneal macrophages. J. Biol. Chem. 271, 28077-28081.
268. Videla, S., Mourelle, M., Vilaseca, J., Salas, A., Tarroch, X., Guarner, F., & Malagelada, J.-R. (1995). The role of nitric oxide synthase in dextran sulfate sodium (DSS) colitis. Gastroenterology 108, A937 (abstract).
269. Vodovotz, V., Bogdan, C., Paik, J., Xie, Q.-W., & Nathan, C. (1993). Mechanisms of macrophage nitric oxide release by transforming growth factor-β. J. Exp. Med. 178, 605-613.
270. Vouldoukis, I., Bécherel, P.-A., Riveros-Moreno, V., Arock, M., da Silva, O., Debré, P., Mazier, D., & Mossalayi, M.D. (1997). Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infnatum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur. J. Immunol. 27, 860-865.
271. Wang, W.W., Jenkinson, C.P., Griscavage, J.M., Kern, R.M., Arabolos, N.S., Byrns, R.E., Cederbaum, S.D., & Ignarro, L.J. (1995). Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Res. Commun. 210, 1009-1016.
272. Wei, X.-Q., Charles, I.G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Xu, D., Muller, W., Moncada, S., & Liew, F.Y. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.
273. Weiner, C.P., Lizasoain, I., Baylis, S.A., Knowles, R.G., Charles, I.G., & Moncada, S. (1994). Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. U.S.A. 91, 5212-5216.
274. Weiss, G., Wachter, H., & Fuchs, D. (1995). Linkage of cell-mediated immunity to iron metabolism. Immunol. Today 16, 495-500.
275. Weisz, A., Oguchi, S., Cicatiello, L., & Esumi, H. (1994). Dual mechanism for the control of inducible-type No synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopoly-saccharide. J. Biol. Chem. 269, 8324-8333.
276. Wong, G.H.W., Kamb, A., & Goeddel, D.V. (1992). Antiviral properties of TNF. In Beutler, B. (Ed.), Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. Raven Press, New York, pp. 371-381.
277. Wright, C.E., Rees, D.D., & Moncada, S. (1992). Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovascular Res. 26, 48-57.
278. Wu, G., & Brosnan, J.T. (1992). Macrophages can convert citrulline into arginine. Biochem. J. 281, 45-48.
279. Xiao, L., Eneroth, P.H., & Quershi, G.A. (1995a). Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity. Scand. J. Immunol. 42, 505-511.
280. Xiao, L., Nilsson, C.G., & Eneroth, P.H. (1995b). Cyclic guanosine3′,5′-mono-phosphate mediates 3-mor-pholinosydnonimine-induced inhibition of human natural killer cells. Biochem. Pharmacol. 50, 147-153.
281. Xie, K., Huang, S., Dong, Z., Juang, S.-H., Gutman, M., Xie, Q.-w., Nathan, C., & Fidler, I.J. (1995a). Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181, 1333-1343.
282. Xie, K., Huang, S., Dong, Z., Gutman, M., & Fidler, I.J. (1995b). Direct correlarion between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res. 55, 3123-3131.
283. Xie, K., Huang, S., Dong, Z., & Fidler, I.J. (1996). Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukoc. Biol. 59, 797-803.
284. Yagi, M.J,. Holland, J.F., & Bekesi, J.G. (1987). Tumor necrosis factor enhances murine SL3-3 retrovirus replication. J. Clin. Lab. Immunol. 24, 129-134.
285. Yamada, T., Sartor, R.B., Marshall, S., Specian, R.D., & Grisham, M.B. (1993). Mucosal unjury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology 104, 759-771.
286. G-nitro-L-arginine and L-arginine on experimental pulmonary metastasis in mice. Cancer Lett. 87, 115-120.
287. Yang, J., Kawamura, I., Zhu, H., & Mitsuyama, M. (1995). Involvement of natural killer cells in nitric oxide production by spleen cells after stimulation with Mycobacterium bovis BCG. Study of the mechanism of the different abilities of viable and killed BCG. J. Immunol. 155, 5728-5735.
288. Yang, W., Ando, J., Korenaga, R., Toyo-Oka, T., & Kamiya, A. (1994). Exo-genous nitric oxide inhibits proliferation of cultured vascular endothelial cells. Biochem. Biophys. Res. Commun. 194, 319-325.
289. Zembala, M., Siedlar, M., Marcinkiewicz, J., & Pryjma, J. (1994). Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not cytokines and lipopolysaccharide. Eur. J. Immunol. 24, 435-439.
290. Ziche, M., Morbidelli, L., Masini, E., Amerini, S., Granger, H.J., Maggi, C.A., Geppetti, P., & Ledda, F. (1994). Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vivo prompted by substance P. J. Clin. Invest. 94, 2036-2044.
291. Zídek, Z., Franková, D., & Otová, B. (1995). Lack of causal relationship between inducibility/severity of adjuvant arthritis in the rat and disease associated changes in production of nitric oxide by macrophages. Ann. rheum. Dis. 54, 325-327.
292. Zídek, Z., Holý, A., & Franková, D. (1997). Antiretroviral agent (R)-9-(2-phos-phonomethoxypropyl)adenine stimulates cytokine and nitric oxide pro-duction. Eur. J. Pharmacol. 331, 245-252.
293. Zielasek, J., Jung, S., Gold, R., Liew, F.Y., Toyka, K.V., & Hartung, H.P. (1995). Administration of nitric oxide synthase inhibitors in expe-rimental autoimmune neuritis and experimental autoimmune ence-phalomyelitis. J. Neuroimmunol. 58, 81-88.